Growth factors in wound healing

Surgical Clinics of North America

Volumn 83, Issue 3, 2003, Pages 531-545

  Cross, Kevin J ^a   Mustoe, Thomas A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; COLLAGEN; COLONY STIMULATING FACTOR; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GROWTH FACTOR; INTERFERON; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VIRUS VECTOR;

CELL PROLIFERATION; CLINICAL TRIAL; DEBRIDEMENT; DIABETIC FOOT; EPITHELIZATION; EXTRACELLULAR MATRIX; GENE THERAPY; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SURGICAL TECHNIQUE; TREATMENT FAILURE; WOUND; WOUND DRESSING; WOUND HEALING;

EID: 0037837212     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(02)00202-5     Document Type: Review

References (60)

1. Steed DL. Modifying the wound healing response with exogenous growth factors. Clin Plast Surg 1998;25:397-404.
2. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68:1-7.
3. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanism of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997;29:5-17.
4. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998;176(Suppl 2A):26S-38S.
5. Ansel J, Berry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990;94:101S-7S.
6. Braunstein S, Kaplan G, Gottlieb AB, et al. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol 1994;103:601-4.
7. Gailit J, Welch MP, Clark RAF. TGFβ1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 1994;103:221-7.
8. Grinnell F. Wound repair, keratinocyte activation and integrin modulation. J Cell Sci 1992;101:1-5.
9. Kiritsy CP, Lynch SE. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med 1993;4:729-60.
10. Clark RAF. Wound repair: overview and general considerations. In: Clark RAF, editor. The molecular and cell biology of wound repair. New York: Plenum Press; 1996. p. 22-32.
11. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor beta-1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-11.
12. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
13. Bennet NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
14. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-10.
15. Pierce GF, Mustoe TA, Altrock BW, et al. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991;45:319-26.
16. Rudkin GH, Miller TA. Growth factors in surgery. Plast Reconstr Surg 1996;97:469-76.
17. LaRochelle WJ, Jeffers M, McDonald WF, et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001;3:517-21.
18. Gilbertson DG, Duff ME, West JW, et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem 2001;6:27406-14.
19. Pierce GF, Brown D, Mustoe TA. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-β1 therapy. J Lab Clin Med 1991;117:373-82.
20. Siegbahn A, Hammacher A, Westermark B, Heldin CH. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest 1990;85:916-20.
21. Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest. 1991;87:694-703.
22. Pierce GF, Mustoe TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1988;167:974-87.
23. Robson MC, Phillips LG, Thomason A, et al. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 1992;339:23-5.
24. Mustoe TA, Cutler NR, Allman RM, et al. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 1994;129:213-9.
25. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 1995;21:71-81.
26. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III, randomized, placebo-controlled, double-blind study. Diabetes Care 1998;21:822-7.
27. d'Hemecourt PA, Smiell JM, Karim MR. Sodium carboxymethylcellulose aqueous-based gel versus becaplermin gel in patients with nonhealing, lower extremity diabetic ulcers. Wounds 1998;10:69.
28. Smiell JM, Wieman TJ, Steed DL, et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999;7:335-46.
29. Cromack DT, Porras-Reyes B, Purdy JA, et al. Acceleration of tissue repair by transforming growth factor beta 1: identification of in vivo mechanism of action with radiotherapy-induced specific healing deficits. Surgery 1993;113:36-42.
30. Montesano R, Orci L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA 1988;85:4894-7.
31. Chen W, Wahl SM. Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect 1999;1:1367-80.
32. Robson MC, Steed DL, McPherson JM, Pratt BM. Use of transforming growth factor β2 (TGF-β2) in treatment of chronic foot ulcers in diabetic patients. 3rd Joint Meeting of the European Tissue Repair Society and the Wound Healing Society, Bordeaux, France, August 23-7, 1999.
33. Wu L, Xia YP, Roth SI, et al. Transforming growth factor-β1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model. Am J Pathol 1999;154:301-8.
34. Xia YP, Zhao Y, Tyrone JW, et al. Differential activation of migration by hypoxia in keratinocytes isolated from donors of increasing age: implication for chronic wounds in the elderly. J Invest Dermatol 2001;116:50-6.
35. Leung D, Chaines G, Kuang W, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
36. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
37. Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990;265:19461-6.
38. Plouet J, Moukadiri H. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem 1990;265:22071-4.
39. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1996;271:21793-7.
40. Taub PJ, Silver L, Weinberg H. Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast Reconstr Surg 1999;105:1034-42.
41. Padubidri A, Browne E Jr. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996;37:604-10.
42. Corral CJ, Siddiqui A, Wu L, et al. Vascular endothelial growth factor is more important than basic fibroblast growth factor during ischemic wound healing. Arch Surg 1999;134:200-5.
43. Lantieri LA, Martin-Garcia N, Wechsler J, et al. Vascular endothelial growth factor expression in expanded tissue: a possible mechanism of angiogenesis in tissue expansion. Plast Reconstr Surg 1998;101:392.
44. Wu L, Pierce GF, Galiano RD, Mustoe TA. Keratinocyte growth factor induces granulation tissue in ischemic dermal wounds: importance of epithelial-mesenchymal interactions. Arch Surg 1996;131:660-6.
45. Beer HD, Gassmann MG, Munz B, et al. Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair. JID Symp Proc 2000;5:34-9.
46. Xia YP, Zhao Y, Marcus J, et al. Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation. J Pathol 1999;188:431-8.
47. Robson MC, Phillips TJ, Falanga V, et al. Randomized trial of topically applied Repifermin (rh-KGF-2) to accelerate wound healing in venous ulcers. Wound Rep Reg (in press).
48. Doukas J, Chandler LA, Gonzalez AM, et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 2001;12:783-98.
49. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-52.
50. Zhao LL, Davidson JD, Wee SC, et al. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 1994;129:1043-9.
51. Bonomo SR, Davidson JD, Tyrone JW, et al. Enhancement of wound healing by hyperbaric oxygen and transforming growth factor beta3 in a new chronic wound model in aged rabbits. Arch Surg 2000;135:1148-53.
52. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
53. Zhang L, Li L, Hoffman GA, Hoffman RM. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem Biophys Res Commun 1996;220:633-6.
54. Titomirov AV, Sukharev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochem Biophys Acta 1991;1088:131-4.
55. Eming SA, Whitsitt JS, He L, et al. Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 1999;112:297-302.
56. Sylvester KG, Nesbit MA, Radu A, et al. Adenoviral-mediated gene transfer in wound healing: acute inflammatory response in human skin in the SCID mouse model. Wound Rep Reg 2000;8:36-44.
57. Slama J, Andree C, Winkler T, et al. Gene transfer. Ann Plast Surg 1995;35:429-39.
58. Crombleholme TM. Adenoviral-mediated gene transfer in wound healing. Wound Rep Reg 2000;8:460-72.
59. Liu PY, Eriksson E, Mustoe TA. Wound healing: practical aspects. In: Russell RC, editor. PSEF Instructional Courses. St. Louis: Mosby; 1991. p. 17-29.
60. Feng Y, Eriksson E. Gene therapy in wound repair and regeneration. Wound Rep Reg 2000;8:443-51.